Quest Diagnostics | DGX - Ebitda


Quest Diagnostics reported $557M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Acadia Healthcare USD 144.22M 44.37M Mar/2026
Agilent USD 456M 84M Dec/2025
Baxter International USD -447M 873M Dec/2025
Bruker USD 110M 101.6M Mar/2026
Cardinal Health USD 1.09B 109M Mar/2026
Centene USD 2.56B 3.47B Mar/2026
Charles River Laboratories USD 229.8M 28.26M Mar/2026
Cigna USD 2.86B 56M Mar/2025
Community Health Systems USD 395M 19M Dec/2025
CVS Health USD 5.83B 2.08B Mar/2026
Danaher USD 1.92B 204M Mar/2026
DaVita Healthcare Partners USD 659.83M 112.87M Mar/2026
Elevance Health USD 4.21B 2.02B Mar/2026
Encompass Health USD 348.8M 13.2M Mar/2026
HCA USD 3.8B 312M Mar/2026
Henry Schein USD 289M 2M Mar/2026
Humana USD 2.06B 2.35B Mar/2026
Illumina USD 469M 137M Dec/2025
IQVIA Holdings USD 932M 114M Mar/2026
Laboratory Of America USD 605.6M 17.5M Mar/2026
McKesson USD 1.88B 206M Dec/2025
Mettler Toledo International USD 278.99M 100.24M Mar/2026
Molina Healthcare USD 267M 385M Mar/2026
Owens Minor USD 90.02M 2.15M Dec/2025
Pediatrix Medical Group USD 65.84M 21.47M Dec/2025
Quest Diagnostics USD 557M 20M Mar/2026
Revvity USD 272.91M 24M Mar/2026
Tenet Healthcare USD 1.16B 21M Mar/2026
Thermo Fisher Scientific USD 2.7B 464M Mar/2026
UnitedHealth USD 9.99B 8.5B Mar/2026
Universal Health Services USD 678.67M 8.07M Dec/2025
Veradigm USD 38.81M 29.61M Sep/2022
Waters USD 380.97M 85.83M Dec/2025
Zoetis USD 939M 101M Dec/2025